Rize Oncology Inc (RIZE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 178 | 135 | 117 | 159 | 339 |
| Operating Income | -178 | -135 | -117 | -159 | -339 |
| Other Income | 8 | 6 | 9 | 15 | 23 |
| Pre-tax Income | -170 | -129 | -108 | -144 | -316 |
| Net Income Continuous | -170 | -129 | -108 | -144 | -316 |
| Net Income | $-170 | $-129 | $-108 | $-144 | $-316 |
| EBITDA(a) | $-178 | $-135 | $-117 | $-159 | $-339 |